| 注册
首页|期刊导航|中华医学杂志(英文版)|Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China

Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China

Ya-Song Wu Wei-Wei Zhang Xue-Mei Ling Lian Yang Shao-Biao Huang Xi-Cheng Wang Hao Wu

中华医学杂志(英文版)2016,Vol.129Issue(3):304-308,5.
中华医学杂志(英文版)2016,Vol.129Issue(3):304-308,5.DOI:10.4103/0366-6999.174509

Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China

Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China

Ya-Song Wu 1Wei-Wei Zhang 1Xue-Mei Ling 2Lian Yang 2Shao-Biao Huang 3Xi-Cheng Wang 4Hao Wu5

作者信息

  • 1. National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
  • 2. Department of Infectious Diseases, The Third People's Hospital of Hengyang City, Hengyang, Hunan 421005, China
  • 3. Department of Infectious Diseases, The Fourth People's Hospital of Nanning City, Nanning, Guangxi 530023, China
  • 4. Department of Infectious Diseases, Yunnan Provincial Infectious Disease Hospital, Kunming, Yunnan 650301, China
  • 5. Center for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China
  • 折叠

摘要

关键词

Antiretroviral Therapy/Co-infection/Hepatitis B Virus/Human Immunodeficiency Virus/Tenofovir Disoproxil Fumarate

Key words

Antiretroviral Therapy/Co-infection/Hepatitis B Virus/Human Immunodeficiency Virus/Tenofovir Disoproxil Fumarate

引用本文复制引用

Ya-Song Wu,Wei-Wei Zhang,Xue-Mei Ling,Lian Yang,Shao-Biao Huang,Xi-Cheng Wang,Hao Wu..Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China[J].中华医学杂志(英文版),2016,129(3):304-308,5.

基金项目

This study was supported by Gilead Sciences (co-us1040405), and in part by the United States CDC Global AIDS Program (GAP) for HBV DNA testing. (co-us1040405)

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量0
|
下载量0
段落导航相关论文